285 related articles for article (PubMed ID: 24887262)
1. Hepatic arterial embolization in patients with neuroendocrine tumors.
Del Prete M; Fiore F; Modica R; Marotta V; Marciello F; Ramundo V; Di Sarno A; Carratù A; di Roseto Cde L; Tafuto S; Tatangelo F; Baldelli R; Colao A; Faggiano A;
J Exp Clin Cancer Res; 2014 May; 33(1):43. PubMed ID: 24887262
[TBL] [Abstract][Full Text] [Related]
2. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.
Kennedy A; Bester L; Salem R; Sharma RA; Parks RW; Ruszniewski P;
HPB (Oxford); 2015 Jan; 17(1):29-37. PubMed ID: 25186181
[TBL] [Abstract][Full Text] [Related]
3. Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.
Fiore F; Del Prete M; Franco R; Marotta V; Ramundo V; Marciello F; Di Sarno A; Carratù AC; de Luca di Roseto C; Colao A; Faggiano A
Endocrine; 2014 Sep; 47(1):177-82. PubMed ID: 24385266
[TBL] [Abstract][Full Text] [Related]
4. [Arterial embolization of hepatic metastases from neuroendocrine tumors].
Libicher M; Bovenschulte H
Radiologe; 2009 Mar; 49(3):233-41. PubMed ID: 19183927
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.
Fiorentini G; Rossi S; Bonechi F; Vaira M; De Simone M; Dentico P; Bernardeschi P; Cantore M; Guadagni S
J Chemother; 2004 Jun; 16(3):293-7. PubMed ID: 15330328
[TBL] [Abstract][Full Text] [Related]
6. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
[TBL] [Abstract][Full Text] [Related]
7. [Radiologically guided interventional therapies for the treatment of neuroendocrine tumors].
Radosa CG; Nebelung H; Schön F; Hoffmann RT
Radiologie (Heidelb); 2024 Jul; 64(7):575-581. PubMed ID: 38761204
[TBL] [Abstract][Full Text] [Related]
8. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
9. Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.
Mayo SC; Herman JM; Cosgrove D; Bhagat N; Kamel I; Geschwind JF; Pawlik TM
J Am Coll Surg; 2013 Jan; 216(1):123-34. PubMed ID: 23063263
[TBL] [Abstract][Full Text] [Related]
10. Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes.
Zener R; Yoon H; Ziv E; Covey A; Brown KT; Sofocleous CT; Thornton RH; Boas FE
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):569-576. PubMed ID: 30627774
[TBL] [Abstract][Full Text] [Related]
11. Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial.
Chen JX; Wileyto EP; Soulen MC
Trials; 2018 Jul; 19(1):390. PubMed ID: 30016989
[TBL] [Abstract][Full Text] [Related]
12. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
Grozinsky-Glasberg S; Kaltsas G; Kaltsatou M; Lev-Cohain N; Klimov A; Vergadis V; Uri I; Bloom AI; Gross DJ
Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for unresectable neuroendocrine liver metastases.
John BJ; Davidson BR
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
[TBL] [Abstract][Full Text] [Related]
14. Hepatic neuroendocrine metastases: chemo- or bland embolization?
Pitt SC; Knuth J; Keily JM; McDermott JC; Weber SM; Chen H; Rilling WS; Quebbeman EJ; Agarwal DM; Pitt HA
J Gastrointest Surg; 2008 Nov; 12(11):1951-60. PubMed ID: 18709512
[TBL] [Abstract][Full Text] [Related]
15. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.
Alagusundaramoorthy SS; Gedaly R
World J Gastroenterol; 2014 Oct; 20(39):14348-58. PubMed ID: 25339822
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine liver metastases.
Reddy SK; Clary BM
Surg Clin North Am; 2010 Aug; 90(4):853-61. PubMed ID: 20637952
[TBL] [Abstract][Full Text] [Related]
17. Hepatic neuroendocrine metastases: does intervention alter outcomes?
Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
[TBL] [Abstract][Full Text] [Related]
18. Management of patients with hepatic metastases from neuroendocrine tumors.
Clift AK; Frilling A
Ann Saudi Med; 2014; 34(4):279-90. PubMed ID: 25811199
[TBL] [Abstract][Full Text] [Related]
19. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.
Kvols LK; Turaga KK; Strosberg J; Choi J
J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Perry LJ; Stuart K; Stokes KR; Clouse ME
Surgery; 1994 Dec; 116(6):1111-6; discussion 1116-7. PubMed ID: 7985095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
